Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.95 USD | -1.67% | +4.98% | -7.23% |
Mar. 07 | Lumos Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 07 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.23% | 24.35M | |
+22.39% | 46.81B | |
-1.65% | 41.37B | |
+47.07% | 41.29B | |
-6.20% | 28.87B | |
+11.44% | 26.06B | |
-21.08% | 19.13B | |
+30.69% | 12.39B | |
+0.10% | 12.08B | |
-0.71% | 11.96B |
- Stock Market
- Equities
- LUMO Stock
- News Lumos Pharma, Inc.
- Lumos Pharma Phase 2 Trials Targeting Pediatric Growth Hormone Deficiency Meet Endpoints; Shares Surge Premarket